Viridian Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VRDN and other ETFs, options, and stocks.About VRDN
Viridian Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of proprietary RNA-targeted therapeutics. Its product candidates include Cobomarsen, which treats patients with certain cancers, including cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma, and Remlarsen and MRG-229, which are made for the treatment of patients with pathological fibrosis.
VRDN Key Statistics
Stock Snapshot
Viridian Therapeutics(VRDN) stock is priced at $32.93, giving the company a market capitalization of 3.14B. It carries a P/E multiple of -9.32.
During the trading session on 2026-01-24, Viridian Therapeutics(VRDN) shares reached a daily high of $33.34 and a low of $31.37. At a current price of $32.93, the stock is +5.0% higher than the low and still -1.2% under the high.
Trading activity shows a volume of 1.96M, compared to an average daily volume of 1.44M.
The stock's 52-week range extends from a low of $9.90 to a high of $34.29.
The stock's 52-week range extends from a low of $9.90 to a high of $34.29.
Analyst ratings
94%
of 18 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.